Compare BHK & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHK | CTKB |
|---|---|---|
| Founded | 2001 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 644.2M | 541.1M |
| IPO Year | N/A | 2021 |
| Metric | BHK | CTKB |
|---|---|---|
| Price | $8.94 | $3.96 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 302.1K | ★ 1.1M |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 8.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | N/A | ★ $193,015,000.00 |
| Revenue This Year | N/A | $5.42 |
| Revenue Next Year | N/A | $7.03 |
| P/E Ratio | $8.73 | ★ N/A |
| Revenue Growth | N/A | ★ 17.67 |
| 52 Week Low | $8.69 | $2.94 |
| 52 Week High | $10.12 | $6.18 |
| Indicator | BHK | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 45.67 | 45.47 |
| Support Level | $8.87 | $3.71 |
| Resistance Level | $9.07 | $4.49 |
| Average True Range (ATR) | 0.06 | 0.22 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 34.21 | 20.97 |
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.